OxyContin Given New Lease On Life By Federal Circuit

Law360, New York (February 1, 2006, 12:00 AM EST) -- In a surprising turnaround, the U.S. Court of Appeals for the Federal Circuit has vacated its earlier ruling that Purdue Pharma’s patents for the blockbuster painkiller OxyContin were unenforceable, throwing the case back into the lower court’s lap for reconsideration.

On Wednesday, The Federal Circuit reversed itself, handing authority back to the U.S. District Court for the Southern District of New York to decide the fate of the OxyContin patent battle, waged between Purdue Pharma and generics drug maker Endo Pharmaceuticals, Inc.

The decision gives hope...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.